Stephen Zaniboni named CFO at Trovagene
This article was originally published in Scrip
Trovagene, a developer of transrenal molecular diagnostics, has appointed Stephen Zaniboni chief financial officer. Mr Zaniboni has previously served as CFO of several companies, including healthcare software solutions company Awarepoint, XIFIN, a provider of revenue cycle management for diagnostic service providers, and AviaraSx, a molecular diagnostic innovator in oncology.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.